Workflow
ClearPoint Neuro(CLPT)
icon
Search documents
ClearPoint Neuro(CLPT) - 2019 Q2 - Earnings Call Transcript
2019-08-12 10:24
MRI Interventions (MRIC) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET Company Participants Joe Burnett - Chief Executive Officer Hal Hurwitz - Chief Financial Officer Operator Greetings and welcome to MRI Interventions, Inc. Second Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. Comments made on this call may include statements that are forward-looking within the meaning of securities laws. These forward-looking statements ma ...
ClearPoint Neuro(CLPT) - 2019 Q1 - Quarterly Report
2019-05-13 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____to _____ Commission file number: 001-34822 MRI Interventions, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 58-2394628 (State or Ot ...
ClearPoint Neuro(CLPT) - 2018 Q4 - Annual Report
2019-04-01 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34822 MRI INTERVENTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 58-2394628 (State or other jurisdi ...